PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress
Abstract
During carcinogenesis, cells are exposed to increased replication stress due to replication fork arrest at sites of DNA lesions and other difficult to replicate regions. Efficient fork restart and DNA repair are important for cancer cell proliferation. We previously showed that the ADP-ribosyltransferase PARP10 interacts with the replication protein PCNA and promotes lesion bypass by recruiting specialized, non-replicative DNA polymerases. Here, we show that PARP10 is overexpressed in a large proportion of human tumors. To understand the role of PARP10 in cellular transformation, we inactivated PARP10 in HeLa cancer cells by CRISPR/Cas9-mediated gene knockout, and overexpressed it in non-transformed RPE-1 cells. We found that PARP10 promotes cellular proliferation and replication fork elongation. Mechanistically, PARP10 overexpression alleviated cellular sensitivity to replication stress by fostering the restart of stalled replication forks. Importantly, mouse xenograft studies indicated that loss of PARP10 reduces the tumorigenesis activity of HeLa cells, while its overexpression results in tumor formation by non-transformed RPE-1 cells. Our findings indicate that PARP10 promotes cellular transformation by alleviating replication stress, and suggest that targeting PARP10 may represent a novel therapeutic approach.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The oncoprotein DEK affects the outcome of PARP1/2 inhibition during replication stress
E. Ferrando-May, M. Ganz, … A. Bürkle·bioRxiv·Feb 19, 2019
- Sustained poly(ADP-ribosyl)ation limits RPA loading and attenuates ATR-CHK1 signaling upon replication fork collapse
Alexandra Mihuț, Debanjan Ghosh, … Gyula Timinszky·bioRxiv·Oct 22, 2025
- TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
Jay Ramanlal Anand, Gaith N. Droby, … Cyrus Vaziri·NAR CancerPeer-reviewed·Jan 15, 2025
- Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis
Gu Xiao, George K. Annor, … Jill Bargonetti·bioRxiv·Mar 28, 2026
- PARP inhibitors affect the replisome and replication fork progression during a single S phase.
Lina-Marie Briu, Chrystelle Antoinat Maric, … Jean‐Charles Cadoret·bioRxiv·Feb 20, 2025
- TSG101 Associates with PARP1 and is Essential for PARylation and DNA Damage-induced NF-κB Activation
Ahmet Buğra Tufan, Katina Lazarow, … Claus Scheidereit·The EMBO JournalPeer-reviewed·Sep 20, 2022